These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1683470

  • 1. Aminopeptidases and angiotensin I-converting enzyme activities in primary human lung tumors and lung parenchyma.
    Procházka J, Krepela E, Sedo A, Viklický J, Fiala P.
    Neoplasma; 1991; 38(5):501-8. PubMed ID: 1683470
    [Abstract] [Full Text] [Related]

  • 2. Increased cathepsin B activity in human lung tumors.
    Krepela E, Kasafírek E, Novák K, Viklický J.
    Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
    [Abstract] [Full Text] [Related]

  • 3. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.
    Varona A, Blanco L, López JI, Gil J, Agirregoitia E, Irazusta J, Larrinaga G.
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F780-8. PubMed ID: 16985214
    [Abstract] [Full Text] [Related]

  • 4. An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung.
    Coursin DB, Cihla HP, Sempf J, Oberley TD, Oberley LW.
    Histol Histopathol; 1996 Oct; 11(4):851-60. PubMed ID: 8930626
    [Abstract] [Full Text] [Related]

  • 5. Enzyme histochemistry of alveolar cell carcinoma.
    Stitnimankarn T, Thakerngpol K, Limsila T, Prijyanonda B.
    J Med Assoc Thai; 1975 Jun; 58(6):299-303. PubMed ID: 167089
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to Bestatin adjuvant therapy.
    Ichimura E, Yamada M, Nishikawa K, Abe F, Nakajima T.
    Pathol Int; 2006 Jun; 56(6):296-300. PubMed ID: 16704492
    [Abstract] [Full Text] [Related]

  • 7. Proteolytic enzymes in human leukemic lymphoid cells. III. Aminopeptidases, angiotensin-converting enzyme, and its inhibitor in cells of different immunological phenotype.
    Lokshina LA, Gureeva TA, Elisseeva YE, Golubeva NV, Kugaevskaya EV, Lubkova ON, Samojlova RS.
    Biochemistry (Mosc); 1999 Apr; 64(4):448-55. PubMed ID: 10231600
    [Abstract] [Full Text] [Related]

  • 8. Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.
    Pérez I, Varona A, Blanco L, Gil J, Santaolalla F, Zabala A, Ibarguen AM, Irazusta J, Larrinaga G.
    Head Neck; 2009 Oct; 31(10):1335-40. PubMed ID: 19373777
    [Abstract] [Full Text] [Related]

  • 9. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Angeletti CA, Bevilacqua G.
    Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
    [Abstract] [Full Text] [Related]

  • 10. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture.
    Baylin SB, Abeloff MD, Goodwin G, Carney DN, Gazdar AF.
    Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807
    [Abstract] [Full Text] [Related]

  • 11. Activity and tissue localization of cathepsin D in non small cell lung cancer.
    Chyczewski L, Płoński A, Chyczewska E, Furman M, Ostrowska H, Nikliński J, Kozłowski M.
    Rocz Akad Med Bialymst; 1997 Jun; 42 Suppl 1():217-29. PubMed ID: 9337539
    [Abstract] [Full Text] [Related]

  • 12. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B, Lötterle H, Schanzenbächer U, Lah TT, Kalman E, Kayser K, Bülzebruck H, Schirren J, Krasovec M, Kos J, Spiess E.
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [Abstract] [Full Text] [Related]

  • 13. [Ca2+, Mg2+-ATPase activity of the erythrocyte membrane in patients with lung cancer].
    Semenchuk DD.
    Eksp Onkol; 1984 Oct; 6(3):72-3. PubMed ID: 6149925
    [Abstract] [Full Text] [Related]

  • 14. Expression of alpha-amylase in human lung cancers.
    Tomita N, Matsuura N, Horii A, Emi M, Nishide T, Ogawa M, Mori T, Doi O, Matsubara K.
    Cancer Res; 1988 Jun 01; 48(11):3292-6. PubMed ID: 2835158
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of neuron-specific enolase as a new tumor marker for carcinoma of the lung].
    Ariyoshi Y.
    Gan No Rinsho; 1984 May 01; 30(6 Suppl):569-73. PubMed ID: 6086970
    [Abstract] [Full Text] [Related]

  • 16. [beta-Glucuronidase in human maxillary sinus and lung cancers: elevation of activity level and appearance of phosphorylated variant forms].
    Fujita M.
    Hokkaido Igaku Zasshi; 1984 Sep 01; 59(5):622-38. PubMed ID: 6096243
    [Abstract] [Full Text] [Related]

  • 17. [Histocytospectrophotometric characteristics of lung cancer].
    Kudriavtsev IuV.
    Arkh Patol; 1980 Sep 01; 42(11):20-7. PubMed ID: 6255907
    [Abstract] [Full Text] [Related]

  • 18. Serum zinc and angiotensin-converting enzyme levels in patients with lung cancer.
    Bakan N, Bakan E, Süerdem M, Yiğitoğlu MR.
    Biofactors; 1988 Jul 01; 1(2):177-8. PubMed ID: 2855586
    [Abstract] [Full Text] [Related]

  • 19. Aspartyl, arginyl and alanyl aminopeptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats.
    Zambotti-Villela L, Yamasaki SC, Villarroel JS, Alponti RF, Silveira PF.
    Brain Res; 2007 Sep 19; 1170():112-8. PubMed ID: 17692297
    [Abstract] [Full Text] [Related]

  • 20. Induction by cortisol of aminopeptidases production from the human placenta in tissue culture.
    Yasuda Y, Mizutani S, Kurauchi O, Kasugai M, Narita O, Tomoda Y.
    Horm Metab Res; 1992 Mar 19; 24(3):110-4. PubMed ID: 1349555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.